Intraoperative use of recombinant activated factor VII during complex aortic surgery

The central role of the propensity score in observational studies for causal effects

Paul R. Rosenbaum, Donald B. Rubin · Biometrika · 1983 · 31K citations · Full text

Public Health, Biostatistics, Causal Inference +16

Thromboembolic Adverse Events After Use of Recombinant Human Coagulation Factor VIIa

Kathryn A. O’Connell · JAMA · 2006 · 673 citations

Medicine, Hematology, Pharmacology +17

Reexploration for bleeding is a risk factor for adverse outcomes after cardiac operations

Michael J. Moulton, Lawrence L. Creswell, Mary E. Mackey et al. · Journal of Thoracic and Cardiovascular Surgery · 1996 · 428 citations · Full text

Medicine, Cardiology, Surgery +15

Prospective, Randomised Trial of Two Doses of rFVIIa (NovoSeven) in Haemophilia Patients with Inhibitors Undergoing Surgery

W. Keith Hoots · Thrombosis and Haemostasis · 1998 · 373 citations

Medicine, Pharmacotherapy, Surgery +12

Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding: a report by the Israeli Multidisciplinary rFVIIa Task Force

U. Martinowitz, Moshe Michaelson · Journal of Thrombosis and Haemostasis · 2005 · 301 citations · Full text

Medicine, Pharmacotherapy, Surgery +12